HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Periocular corticosteroid injection in the management of uveitis in children.

AbstractPURPOSE:
To report the outcome of orbital floor corticosteroid injection (OFCI) in the management of uveitis in children.
METHODS:
  A retrospective noncomparative interventional case series. The medical records of 15 consecutive children (19 eyes) with various forms of uveitis treated with OFCI of 40 mg/ml methylprednisolone acetate or a combination of 20 mg/0.5 ml Triamcinolone and 2 mg/0.5 ml dexamethasone were reviewed. Data were collected 6 months postinjection and included details of uveitis, best corrected visual acuity (BCVA), ocular inflammation, systemic therapy required and potential complications of OFCI.
RESULTS:
The mean BCVA improvement was 0.18 logarithm of the minimum angle of resolution (p < 0.001), at a mean of 6 weeks (range, 4-20). Fourteen eyes (74%) had significant improvement in inflammation, 4-7 weeks post-OFCI, with a median of 4 weeks. Anterior uveitis was treated effectively in all eyes, vitritis resolved in all but one case and resolution of cystoid macular oedema was achieved in six eyes (55%). Uveitis relapsed in seven eyes (50%) after a median time of 4 months (range, 2-5 months). Four eyes (21%) underwent more than one injection. The dosage of immunosuppressive systemic therapy was reduced or able to be stopped in three patients (50%). Steroid-induced cataract was observed in four eyes (21%), 5 months post-OFCI. One patient developed cushingoid features 6 weeks post his second OFCI.
CONCLUSION:
Corticosteroid orbital floor injections resulted in control of active uveitis and visual acuity improvement in most children. However, the effect might be transient and induce cataract formation.
AuthorsZohar Habot-Wilner, Ahmed Sallam, Athena Roufas, Paul Mb Kabasele, John R Grigg, Peter McCluskey, Sue Lightman
JournalActa ophthalmologica (Acta Ophthalmol) Vol. 88 Issue 8 Pg. e299-304 (Dec 2010) ISSN: 1755-3768 [Electronic] England
PMID21114631 (Publication Type: Journal Article)
Copyright© 2010 The Authors. Acta Ophthalmologica © 2010 Acta Ophthalmologica Scandinavica Foundation.
Chemical References
  • Glucocorticoids
  • Methylprednisolone Acetate
  • Dexamethasone
  • Triamcinolone Acetonide
  • Methylprednisolone
Topics
  • Adolescent
  • Cataract (chemically induced)
  • Cataract Extraction
  • Child
  • Child, Preschool
  • Dexamethasone (administration & dosage, adverse effects)
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids (administration & dosage, adverse effects)
  • Humans
  • Injections, Intraocular
  • Male
  • Methylprednisolone (administration & dosage, adverse effects, analogs & derivatives)
  • Methylprednisolone Acetate
  • Orbit
  • Retrospective Studies
  • Treatment Outcome
  • Triamcinolone Acetonide (administration & dosage, adverse effects)
  • Uveitis (drug therapy, physiopathology)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: